BRIEF-Ipsen announces Health Canada approval of dysport therapeutic for treatment of patients with cervical dystonia

* Ipsen announces health canada approval of dysport therapeutic™ (abobotulinumtoxina) for the treatment of patients with cervical dystonia and adult upper limb spasticity Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.